Showing results (161-170 of 176) with videos related to

Sort By:
Pageof 18
Aging Clinical and Experimental Research|May 3, 2020
A National Multicenter Study on overall survival in elderly metastatic castrate-resistant prostate cancer patients treated with Radium-223Viviana Frantellizzi, Fabio Monari, Manlio Mascia, et al.
Cancers|September 14, 2019
18F-Facbc in Prostate Cancer: A Systematic Review and Meta-AnalysisRiccardo Laudicella, Domenico Albano, Pierpaolo Alongi, et al.
European Journal of Nuclear Medicine and Molecular Imaging|January 3, 2026
Machine learning for automated differentiation of parkinson's disease and its mimics using ¹²³I-mIBG scintigraphy: insights from a multicentre real-world cohort (ITA-mIBG study)Luca Filippi, Francesco Bianconi, Viviana Frantellizzi, et al.
Biomedicines|May 16, 2023
The DASciS Software for BSI Calculation as a Valuable Prognostic Tool in mCRPC Treated with 223RaCl2: A Multicenter Italian StudyMaria Silvia De Feo, Viviana Frantellizzi, Matteo Bauckneht, et al.
Plos One|February 25, 2010
Genetically determined measures of striatal D2 signaling predict prefrontal activity during working memory performanceAlessandro Bertolino, Paolo Taurisano, Nicola Marco Pisciotta, et al.
Frontiers in Behavioral Neuroscience|July 30, 2014
Prefronto-striatal physiology is associated with schizotypy and is modulated by a functional variant of DRD2Paolo Taurisano, Raffaella Romano, Marina Mancini, et al.
European Journal of Nuclear Medicine and Molecular Imaging|September 6, 2021
The prognostic power of inflammatory indices and clinical factors in metastatic castration-resistant prostate cancer patients treated with radium-223 (BIO-Ra study)Matteo Bauckneht, Sara Elena Rebuzzi, Alessio Signori, et al.
Diagnostics (Basel, Switzerland)|February 13, 2025
Large Italian Multicenter Study on Prognostic Value of Baselines Variables in mCRPC Patients Treated with 223RaCl2: Ten Years of Clinical ExperienceMaria Silvia De Feo, Luca Filippi, Matteo Bauckneht, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|March 5, 2026
Diagnostic Yield of [18F]FDG PET/CT in FUO: An Italian Multicenter Study of 929 PatientsDomenico Albano, Francesco Lanfranchi, Matteo Bauckneht, et al.
Clinical Lymphoma, Myeloma & Leukemia|May 10, 2018
Italian Multicenter Study on Accuracy of 18F-FDG PET/CT in Assessing Bone Marrow Involvement in Pediatric Hodgkin LymphomaAngelina Cistaro, Laura Cassalia, Cinzia Ferrara, et al.
Pageof 18